Theoretical investigation on nevirapine and HIV-1 reverse transcriptase binding site interaction, based on ONIOM method
Authors:
- 21 October 2003
- journal article
- research article
- Published by Elsevier in Chemical Physics Letters
- Vol. 380 (3-4) , 456-463
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Conformational analysis of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, based on quantum mechanical calculationsJournal of Computer-Aided Molecular Design, 2001
- Molecular Calculations on the Conformation of the HIV-1 Reverse Transcriptase Inhibitor (+)-( S)-4,5,6,7-Tetrahydro-8-chloro-5-methyl-6-(3-methyl-2-butenyl)-imidazo[4,5,1- jk][1,4] benzodiazepine-2(1 H)-thione (8-Chloro- TIBO)Monatshefte für Chemie - Chemical Monthly, 2001
- Use of MM-PBSA in Reproducing the Binding Free Energies to HIV-1 RT of TIBO Derivatives and Predicting the Binding Mode to HIV-1 RT of Efavirenz by Docking and MM-PBSAJournal of the American Chemical Society, 2001
- The Y181C Mutant of HIV-1 Reverse Transcriptase Resistant to Nonnucleoside Reverse Transcriptase Inhibitors Alters the Size Distribution of RNase H CleavagesBiochemistry, 2001
- Estimation of Binding Affinities for HEPT and Nevirapine Analogues with HIV-1 Reverse Transcriptase via Monte Carlo SimulationsJournal of Medicinal Chemistry, 2000
- The HIV-1 Reverse Transcription (RT) Process as Target for RT InhibitorsMedicinal Research Reviews, 2000
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: Strategies to overcome drug resistance developmentMedicinal Research Reviews, 1996
- THE RETROVIRAL ENZYMESAnnual Review of Biochemistry, 1994
- HIV resistance to reverse transcriptase inhibitorsBiochemical Pharmacology, 1994
- Molecular Targets for AIDS TherapyScience, 1990